Misclassified Events in Pharma and Medtech Can Trigger Penalties and Waste—Here’s How to Prevent That
April 22, 2025
You are not permitted to access this page. Please purchase membership to get full access to all articles.
Become a Member
Source: Igor Omilaev, Quality Digest
Misunderstanding the difference between deviation and nonconformance can lead to costly quality mistakes in pharma, biotech, and medical device industries.
Most popular blogs
-
Understanding NDC in Measurement System Analysis - Automotive Quality SolutionsJuly 2, 2024ISO 9001 Revision Pushed to 2026?September 4, 2024What's the difference between PDCA and a Management System?July 25, 2024Classification of Medical Devices under EU MDRAugust 21, 2024Avoiding Common Pitfalls in ISO 27001 ImplementationJanuary 21, 2025100 quality tools in 200 minutes: How Fishbone Diagram Tackles Root CausesSeptember 25, 2024Writing Clear Control Descriptions for SOC 2 and ISO 27001 with Expert PrecisionMarch 11, 2025Introducing the ISMS Copilot X, a cross-framework assistantJuly 25, 2024ISO 9001 Revision Criticized for Diluting Quality StandardsDecember 10, 2024Auditing: Finding Faults or Issuing Opinions?October 30, 2024